309 related articles for article (PubMed ID: 1923514)
1. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
Askew DS; Ashmun RA; Simmons BC; Cleveland JL
Oncogene; 1991 Oct; 6(10):1915-22. PubMed ID: 1923514
[TBL] [Abstract][Full Text] [Related]
2. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
Packham G; Cleveland JL
Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
[TBL] [Abstract][Full Text] [Related]
3. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.
Packham G; Porter CW; Cleveland JL
Oncogene; 1996 Aug; 13(3):461-9. PubMed ID: 8760287
[TBL] [Abstract][Full Text] [Related]
4. Regulation of c-myc and ornithine decarboxylase expression by distinct protein kinase systems in IL-3-dependent myeloid cells.
Farrar WL; Willette-Brown J; Linnekin D
Lymphokine Cytokine Res; 1991 Aug; 10(4):291-9. PubMed ID: 1718453
[TBL] [Abstract][Full Text] [Related]
5. Deregulated c-myc expression overrides IFN gamma-induced macrophage growth arrest.
Vairo G; Vadiveloo PK; Royston AK; Rockman SP; Rock CO; Jackowski S; Hamilton JA
Oncogene; 1995 May; 10(10):1969-76. PubMed ID: 7761098
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 3-dependent proliferation of the human Mo-7e cell line is supported by discrete activation of late G1 genes.
Avanzi GC; Porcu P; Brizzi MF; Ghigo D; Bosia A; Pegoraro L
Cancer Res; 1991 Mar; 51(6):1741-3. PubMed ID: 1998964
[TBL] [Abstract][Full Text] [Related]
8. Down-modulation of c-myc expression by phorbol ester protects CEM T leukaemia cells from starvation-induced apoptosis: role of ornithine decarboxylase and polyamines.
Tiberio L; Maier JA; Schiaffonati L
Cell Death Differ; 2001 Oct; 8(10):967-76. PubMed ID: 11598794
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
Walton MI; Whysong D; O'Connor PM; Hockenbery D; Korsmeyer SJ; Kohn KW
Cancer Res; 1993 Apr; 53(8):1853-61. PubMed ID: 8467505
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.
Bullock G; Tang C; Tourkina E; Ibrado AM; Lutzky J; Huang Y; Mahoney ME; Bhalla K
Exp Hematol; 1993 Dec; 21(13):1640-7. PubMed ID: 8243566
[TBL] [Abstract][Full Text] [Related]
12. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
Dolnikov A; Millington M; Sun LQ; Symonds G
Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
[TBL] [Abstract][Full Text] [Related]
13. v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells.
Cleveland JL; Troppmair J; Packham G; Askew DS; Lloyd P; González-Garcia M; Nuñez G; Ihle JN; Rapp UR
Oncogene; 1994 Aug; 9(8):2217-26. PubMed ID: 8036007
[TBL] [Abstract][Full Text] [Related]
14. c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitor.
Russo P; Arzani D; Trombino S; Falugi C
J Pharmacol Exp Ther; 2003 Jan; 304(1):37-47. PubMed ID: 12490573
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.
Ausserlechner MJ; Obexer P; Böck G; Geley S; Kofler R
Cell Death Differ; 2004 Feb; 11(2):165-74. PubMed ID: 14576768
[TBL] [Abstract][Full Text] [Related]
16. The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells.
Albert DA
J Clin Invest; 1995 Apr; 95(4):1490-6. PubMed ID: 7706453
[TBL] [Abstract][Full Text] [Related]
17. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
[TBL] [Abstract][Full Text] [Related]
18. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
[TBL] [Abstract][Full Text] [Related]
19. Cell-cycle progression is not essential for c-Myc to block differentiation.
Ryan KM; Birnie GD
Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
[TBL] [Abstract][Full Text] [Related]
20. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
